Ms Charan Sandhu > Weil, Gotshal & Manges LLP > New York, United States > Lawyer Profile
Weil, Gotshal & Manges LLP Offices
767 5TH AVENUE
NEW YORK, NY 10153
NEW YORK
United States
- Firm Profile
- Go to...
Ms Charan Sandhu
Position
Partner
Career
Charan Sandhu is Co-Head of Weil’s Technology & IP Transactions practice and a member of the Firm’s Privacy & Cybersecurity group. She represents clients in matters relating to technology transfer and the development, acquisition, use and commercial exploitation of technology and intellectual property. She has extensive experience in negotiating and structuring international technology and IP transactions ranging from joint ventures and strategic alliances, patent licenses, co-marketing and co-promotion arrangements, IP acquisitions and divestitures (including of large patent portfolios), technology transfer and outsourcing to settlements of IP litigation. Her practice encompasses a wide range of technologies, including consumer electronics, computer hardware and software, semiconductor devices and manufacturing equipment and processes, biotechnology, pharmaceuticals, medical devices, communications (network and telephony) and the Internet.
Education
UC Berkeley (B.S., 1993); Georgetown University Law Center (J.D., 1998).
Lawyer Rankings
United States > Intellectual property > Patents: licensing
(Leading lawyers)Weil, Gotshal & Manges LLP handles licensing issues in regard to M&A, private equity, banking & finance and restructuring matters. The firm advises a number of global clients on licensing arrangements, patent acquisitions and other agreements and collaborations. Michael Epstein has more than extensive experience advising technology companies and industry investors on transactions. Charan Sandhu leads the team, with a practice focused on a variety of transactions, such as private equity and M&A, including licensing agreements, while co-head Jeffrey Osterman is vastly experienced in technology-related aspects of transactions. All listed attorneys are based in New York.
Weil, Gotshal & Manges LLP handles licensing issues in regard to M&A, private equity, banking & finance and restructuring matters. The firm advises a number of global clients on licensing arrangements, patent acquisitions and other agreements and collaborations. Michael Epstein has more than extensive experience advising technology companies and industry investors on transactions. Charan Sandhu leads the team, with a practice focused on a variety of transactions, such as private equity and M&A, including licensing agreements, while co-head Jeffrey Osterman is vastly experienced in technology-related aspects of transactions. All listed attorneys are based in New York.
United States > Media, technology and telecoms > Technology transactions
(Leading lawyers)Weil, Gotshal & Manges LLP has extremely good experience representing companies and investors operating in the technology and life sciences industries. The team has developed good credentials for standalone technology and IP deals, including advice on patent acquisitions and divestitures, licensing arrangements, research and development collaborations, and technology and IP-focused joint ventures and strategic alliances. A recent highlight included advising Eli Lilly and Company on a license agreement to acquire exclusive global rights to antibody-drug conjugates for the targeted treatment of cancer from ImmunoGen. This expertise feeds through into the broader support the team provides to the corporate finance group, including advice on corporate M&A and private equity buyouts, banking and finance transactions, and restructuring matters. Jeffrey Osterman and Charan Sandhu jointly lead the market-leading team, which also includes Karen Ballack in Silicon Valley, and the department’s founder and former head, Michael Epstein. All partners are based in New York unless otherwise stated.
United States > Healthcare > Life sciences
Working across offices in New York and California, the team at Weil, Gotshal & Manges LLP has a ‘wide and deep knowledge’ of life sciences related antitrust, IP, and M&A matters. The team often advises biotech, medical devices, and pharmaceutical companies on licensing agreements, commercial litigations, and false advertising issues. Edward Reines co-heads the practice from Silicon Valley, contributing his broad knowledge of willful patent infringement and contentious IP issues, while New York-based co-head Elizabeth Weiswasser is known for her focus on life science patent litigation, often appearing before the PRAB and ITC for pharmaceutical companies. Jeffrey Osterman and Charan Sandhu jointly lead the technology and IP transactions practice from New York, leveraging their expertise in joint developing agreements, strategic alliances, and technology transfer agreements. Based in Silicon Valley, Derek Walter is noted for his life sciences IP litigation capabilities.
Lawyer Rankings
- Leading lawyers United States > Media, technology and telecoms > Technology transactions
- Leading lawyers United States > Intellectual property > Patents: licensing
- Patents: licensing United States > Intellectual property
- Technology transactions United States > Media, technology and telecoms
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Tax > US taxes: non-contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: equity offerings
- Intellectual property > Copyright
- Tax > Financial products
- Tax > International tax
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Media and entertainment: litigation
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Finance > Structured finance: securitization
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: oil and gas
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Industry focus > Sport
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trademarks: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense